Last reviewed · How we verify
Licensed mRNA vaccine — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Licensed mRNA vaccine (Licensed mRNA vaccine) — AstraZeneca.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Licensed mRNA vaccine TARGET | Licensed mRNA vaccine | AstraZeneca | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Licensed mRNA vaccine CI watch — RSS
- Licensed mRNA vaccine CI watch — Atom
- Licensed mRNA vaccine CI watch — JSON
- Licensed mRNA vaccine alone — RSS
Cite this brief
Drug Landscape (2026). Licensed mRNA vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/licensed-mrna-vaccine. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab